Similar Articles
571 Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment
572 Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report
573 Role of modern radiotherapy in managing patients with hepatocellular carcinoma
574 Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma
575 Liver resection for hepatocellular carcinoma larger than 10 cm: A multi-institution long-term observational study
576 Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations
577 Cellular based treatment modalities for unresectable hepatocellular carcinoma
578 Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
579 Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
580 Skeletal muscle metastases of hepatocellular carcinoma: A case report and literature review
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA